Clinical trials begin for anti-obesity device

01/17/2013 | Boston Herald

An anti-obesity device that forms a physical barrier between food and part of the intestine has achieved reductions in blood sugar levels and weight loss, according to the developer, GI Dynamics. The company has started clinical trials of the EndoBarrier, which is targeted at obese patients with type 2 diabetes.

View Full Article in:

Boston Herald

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI